Saturday, October 30, 2021

Dr Reddy's Laboratories working on enhancing Covid-19 portfolio

As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator

from Today's Paper https://ift.tt/2XVXJxO
via

No comments:

Post a Comment

If you have any doubts please let me know!

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...